Profil
Todd A. Huffman is the founder of Padlock Therapeutics, Inc., which was founded in 2014.
He holds the title of Director at Padlock Therapeutics, Inc. Dr. Huffman is currently working as the Director-Clinical Translation Initiative at The University of Virginia School of Medicine.
Dr. Huffman previously worked as an Analyst at RCT BioVentures from 2007 to 2010.
Dr. Huffman obtained a doctorate degree from the University of Virginia in 2005.
Aktive Positionen von Todd A. Huffman
| Unternehmen | Position | Beginn |
|---|---|---|
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Gründer | 01.01.2014 |
The University of Virginia School of Medicine
The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Todd A. Huffman
| Unternehmen | Position | Ende |
|---|---|---|
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Private-Equity-Analyst | 30.03.2010 |
Ausbildung von Todd A. Huffman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RCT BioVentures
RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements. | Finance |
The University of Virginia School of Medicine
The University of Virginia School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
















